logo
搜索
菜单

Antagonist的搜索结果

当前1/3页
排序: 最近更新
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds 10.3791/53124-v
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Measurement of Smooth Muscle Function in the Isolated Tissue Bath-applications to Pharmacology Research 10.3791/52324-v
Measurement of Smooth Muscle Function in the Isolated Tissue Bath-applications to Pharmacology Research
Isolating and Using Sections of Bovine Mesenteric Artery and Vein as a Bioassay to Test for Vasoactivity in the Small Intestine 10.3791/52020-v 07:32 min
Isolating and Using Sections of Bovine Mesenteric Artery and Vein as a Bioassay to Test for Vasoactivity in the Small Intestine
Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists 10.3791/51085-v 10:51 min
Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Manufacturing and Using Piggy-back Multibarrel Electrodes for In vivo Pharmacological Manipulations of Neural Responses 10.3791/4358-v
Manufacturing and Using Piggy-back Multibarrel Electrodes for In vivo Pharmacological Manipulations of Neural Responses
22.4: Hypertension IV: Drug Therapy and Lifestyle Modifications 01:28 min
22.4: Hypertension IV: Drug Therapy and Lifestyle Modifications
Cell-based Calcium Assay for Medium to High Throughput Screening of TRP Channel Functions using FlexStation 3 10.3791/3149-v 07:26 min
Cell-based Calcium Assay for Medium to High Throughput Screening of TRP Channel Functions using FlexStation 3
Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice 10.3791/3124-v 07:09 min
Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice
9.6: Barrett Esophagus-II: Clinical Manifestations and Management 01:21 min
9.6: Barrett Esophagus-II: Clinical Manifestations and Management
Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis 10.3791/2737-v
Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis
Measuring Motor Coordination in Mice 10.3791/2609-v
Measuring Motor Coordination in Mice
Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3 10.3791/2531-v
Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
24.4: Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists 01:29 min
24.4: Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
24.3: Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists 01:28 min
24.3: Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
24.2: Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists 01:27 min
24.2: Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
23.2: Drugs for Treatment of Diarrhea-Predominant IBS 01:17 min
23.2: Drugs for Treatment of Diarrhea-Predominant IBS
22.4: Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists 01:28 min
22.4: Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
21.4: Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists 01:28 min
21.4: Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
20.3: Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists 01:18 min
20.3: Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
19.5: Antiasthma Drugs: Muscarinic Receptor Antagonists 01:20 min
19.5: Antiasthma Drugs: Muscarinic Receptor Antagonists
返回顶部